Skip to main content
Equibles
HURA logo

HURA · TuHURA Biosciences, Inc. · Metrics

Track HURA — free

Use HURA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HURA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.01 -0.08 (-3.60%) At close · Oct 22
Rebalance outlook locked
Market Cap
$128.09M
Shares
63.73M
Volume · Oct 22 609.26K Avg daily vol (3M) 240.34K

HURA metrics

66 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.01
Market cap
$128.09M

Price action

20 metrics
Price change (1W)
+9.8%
Price change (30D)
-5.6%
Price change (3M)
-6.5%
Price change (6M)
-12.2%
Price change (YTD)
+165.5%
Price change (1Y)
-10.7%
Trailing year
Price change (5Y)
—
52-week high
$3.15
52-week low
$0.44
Change from 52-week high
-36.2%
Change from 52-week low
+356.8%
Annualized volatility
130.2%
Annualized volatility (3M)
68.2%
Beta
3.1
RSI (14D)
53.0
Price vs SMA 50
-1.8%
Price vs SMA 200
+4.0%
Avg volume (3M)
240,307
Relative volume
2.5
Average dollar volume
$504,477

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
63.73M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
7.2
reciprocal yield 13.9%
FCF yield
-22.5%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-23.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$11,516
Net income (TTM)
−$30.62M
Trailing 12 months
Diluted EPS (TTM)
$-0.54
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-0.04
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-0.54
Operating cash flow per diluted share (TTM)
$-0.53
Free cash flow per diluted share (TTM)
$-0.54
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$0.40
Stock compensation per diluted share (TTM)
$0.15
Book value per share
$0.35

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+43.6%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-165.5%
Return on assets
-96.5%
Debt / equity
0.2
Current ratio
0.2
EBITDA (TTM)
—
Free cash flow (TTM)
−$29.90M
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$2.60M
Latest balance sheet
Cash & equivalents
$995,977
Total assets
$31.75M
Total debt
$3.60M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$29.69M
Capital expenditures (TTM)
$213,674
R&D (TTM)
$22.88M
SG&A (TTM)
—
Stock compensation (TTM)
$8.53M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
89
13F filer change QoQ
-1
Institutional ownership
14.1%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
3.7%
Private-fund adviser ownership
2.9%
Active holders' share change QoQ
+24.1%
Holder tenure
4.0
Price vs estimated holder cost
+14.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
5.7%

Short interest

3 metrics
Short interest
9.6%
Latest settlement · 28.4 days to cover
Days to cover
28.4d
Short-squeeze score
71 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1498382 CUSIP 898920103 13F (30d) 12 filings 12 filers Visit website Investor relations